Stochastic modeling to determine the economic effects of blanket, selective, and no dry cow therapy

Journal of Dairy Science

Volumn 90, Issue 3, 2007, Pages 1225-1234

  Huijps, K ^a   Hogeveen, H ^a,b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Dry cow therapy; Economics; Mastitis; Stochastic

Indexed keywords

ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS UBERIS;

EID: 34047221004     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.S0022-0302(07)71611-9     Document Type: Article

References (26)

1. Berry, E. A., and J. E. Hillerton. 2002a. The effect of an intramammary teat seal on new intramammary infections. J. Dairy Sci. 85:2512-2520.
2. Berry, E. A., and J. E. Hillerton. 2002b. The effect of selective dry cow treatment on new intramammary infections. J. Dairy Sci. 85:112-121.
3. Berry, S. L., J. Maas, J. H. Kirk, J. P. Reynolds, I. A. Gardner, and A. Ahmadi. 1997. Effects of antimicrobial treatment at the end of lactation on milk yield, somatic cell count, and incidence of clinical mastitis during the subsequent lactation in a dairy herd with a low prevalence of contagious mastitis. J. Am. Vet. Med. Assoc. 211:207-211.
4. Bradley, A. J., and M. J. Green. 2000. A study of the incidence and significance of intramammary enterobacterial infections acquired during the dry period. J. Dairy Sci. 83:1957-1965.
5. Bradley, A. J., and M. J. Green. 2001. An investigation of the impact of intramammary antibiotic dry cow therapy on clinical coliform mastitis. J. Dairy Sci. 84:1632-1639.
6. DeVos, C. J., and A. A. Dijkhuizen. 1998. Economic aspects of mastitis and mastitis prevention. Internal Report. Department of Animal Health Economics, Wageningen University, the Netherlands, [in Dutch]
7. Dingwell, R. T., T. F. Duffield, K. E. Leslie, G. P. Keefe, L. DesCoteaux, D. F. Kelton, K. D. Lissemore, Y. H. Schukken, P. Dick, and R. Bagg. 2002. The efficacy of intramammary tilmicosin at drying-off, and other risk factors for the prevention of new intramammary infections during the dry period. J. Dairy Sci. 85:3250-3259.
8. Dingwell, R. T., D. F. Kelton, and K. E. Leslie. 2003. Management of the dry cow in control of peripartum disease and mastitis. Vet. Clin. North Am. Food Anim. Pract. 19:235-265.
9. Dodd, F. H., D. R. Westgarth, F. K. Neave, and R. G. Kingwell. 1969. Mastitis - The strategy of control. J. Dairy Sci. 52:689-695.
10. Godden, S., P. Rapnicki, S. Stewart, J. Fetrow, A. Johnson, R. Bey, and R. Farnsworth. 2003. Effectiveness of an internal teat seal in prevention of new intramammary infections during the dry and early-lactation periods in dairy cows when used with a dry cow intramammary antibiotic. J. Dairy Sci. 86:3899-3911.
11. Green, M. J., L. E. Green, A. J. Bradley, P. R. Burton, Y. H. Schukken, and G. F. Medley. 2005. Prevalence and associations between bacterial isolates from dry mammary glands of dairy cows. Vet. Rec. 156:71-77.
12. Hogan, J. S., K. L. Smith, D. A. Todhunter, and P. S. Schoenberger. 1994. Efficacy of dry cow therapy and a Propionibacterium acnes product in herds with low somatic cell count. J. Dairy Sci. 77:3331-3337.
13. Hogan, J. S., K. L. Smith, D. A. Todhunter, and P. S. Schoenberger. 1995. Efficacy of recombinant bovine interleukin-2 as an adjunct to dry cow therapy. J. Dairy Sci. 78:1062-1067.
14. Houben, E. H. P., A. A. Dijkhuizen, J. A. M. van Arendonk, and R. B. M. Huirne. 1993. Short- and long-term production losses and repeatability of clinical mastitis in dairy cattle. J. Dairy Sci. 76:2561-2578.
15. Houben, E. H. P., R. B. M. Huirne, A. A. Dijkhuizen, and A. R. Kristensen. 1994. Optimal replacement of mastitis cows determined by a hierarchic Markov process. J. Dairy Sci. 77:2975-2993.
16. Huxley, J. N., M. J. Green, L. E. Green, and A. J. Bradley. 2002. Evaluation of the efficacy of an internal teat sealer during the dry period. J. Dairy Sci. 85:551-561.
17. Kuiper, D., J. Jansen, R. J. Renes, C. Leeuwis, and H. van der Zwaag. 2005. Social factors related to mastitis control practices: The role of dairy farmers' knowledge, attitude, values, behaviour and networks. Pages 576-582 in Mastitis in Dairy Production: Current Knowledge and Future Solutions. Proc. 4th Int. Dairy Fed. Int. Mastitis Conf., Maastricht, the Netherlands. Wageningen Academic Publishers, Wageningen, the Netherlands.
18. McDougall, S. 2003. Management factors associated with the incidence of clinical mastitis over the non-lactation period and bulk tank somatic cell count during the subsequent lactation. N.Z. Vet. J. 51:63-72.
19. McNab, W. B., and A. H. Meek. 1991. A benefit cost analysis of dry-cow mastitis therapy in dairy cattle in Ontario. Can. Vet. J. 32:347-353.
20. Østerås, O. 2000. The costs of mastitis - An opportunity to gain more money. Page 67-77 in Proc. British Mastitis Conf. Institute for Animal Health. Milk Development Council, Shepton Mallet, UK.
21. Østerås, O., J. Aursjo, G. G. Gjul, and A. Jorstad. 1994. Effect of dry-cow therapy on subclinical mastitis - An evaluation of long-acting and short-acting intramammaria. J. Vet. Med. B 41:529-540.
22. Østerås, O., L. Sandvik, J. Aursjo, G. G. Gjul, and A. Jorstad. 1991. Assessment of strategy in selective dry cow therapy for mastitis control. J. Vet. Med. B 38:513-522.
23. Robert, A., H. Seegers, and N. Bareille. 2006. Incidence of intramammary infections during the dry period without or with antibiotic treatment in dairy cows - A quantitative analysis of published data. Vet. Res. 37:25-48.
24. Schukken, Y. H., J. Vanvliet, D. Vandegeer, and F. J. Grommers. 1993. A randomized blind trial on dry cow antibiotic infusion in a low somatic cell count herd. J. Dairy Sci. 76:2925-2930.
25. Van der Walle, K. 2004. Gebruikswaarde van melkvee. Internal report. Animal Sciences Group Wageningen UR, Lelystad, the Netherlands.
26. Vose, D. 2000. Defining distributions from expert opinion. Pages 262271 in Risk Analysis: A Quantitative Guide. 2nd ed. John Wiley & Sons, Chichester, UK.